Market
Scenario:
The pharmaceutical industry is experiencing a dramatic
change. Pipeline challenges, pricing pressures, and emerging global markets are
redesigning the way these companies operate. Providers to the pharmaceutical
industry, such as contract manufacturers, will need to alter as well. In the
year to come, contract manufacturers that distinguish their offerings and
abilities will be able to retain customers and grow their business within this
highly competitive marketplace.
Another reason for increasing prospect in
pharmaceutical contract development services is found in the growth of
developing biotech’s. Most of these companies are heavily dedicated to the
development of drug compounds to address a specific therapeutic area.
Sample
Report @ https://www.marketresearchfuture.com/sample_request/1532
The global Pharmaceutical Contract Manufacturing market
is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.
Top
Key Players:
Some of key the players in the market are Catalant,
Boehringer Ingelheim, Lonza AG, Grifols International, S.A, AbbVie Inc, Patheon
Inc., Vetter, Pharmaceutical Product Development and others.
Segmentation:
The global Pharmaceutical Contract Manufacturing market
is segmented on the basis of type, On the basis of type, the market is
classified into Active Pharmaceutical Ingredient (API) Manufacturing, Finished
Dosage Formulation (FDF) Market.
Key
Findings:
The global Pharmaceutical Contract Manufacturing market
is expected to reach USD 107,004.0 million by 2023 at a CAGR of 7.2%.
On the basis of types, Active Pharmaceutical Ingredient
(API) Manufacturing segment is expected to command the largest market share of
7% over the review period and Finished Dosage Formulation (FDF) Secondary
Market is expected to grow at the fastest CAGR of 6.5% during the forecast
period 2017-2023
The Americas hold the largest share of the
Pharmaceutical Contract Manufacturing market and is expected to reach USD
40,041.5 million by 2023
Asia Pacific is the fastest growing market, which is
expected to grow at a CAGR of 7.7% over the 2017-2023
More
Details @ https://www.marketresearchfuture.com/reports/pharmaceutical-contract-manufacturing-market-1532
Low tech pharmaceutical contract manufacturing
manufacture is shifting to the developing world especially China and India. The
developed regions must accommodate this shift by shifting to high tech segment
of the pharmaceutical contract manufacturing market such as biologics.
China has feverously increased its capacity for API
manufacturing while India is a better destination for formulation development
and manufacturing.
Regional
Analysis:
The Americas dominate the Pharmaceutical Contract
Manufacturing market owing to the well-developed technology, high healthcare
expenditure, improvement in reimbursement scenario, and the presence of the
leading players.
Europe holds the second position in the Pharmaceutical
Contract Manufacturing market. It is expected that the support provided by the
government bodies for research & development, and drives the market in
European region.
Asia Pacific region is projected to be the fastest
growing region during the forecast period. Rapidly improving technology, and
the presence of huge patient pool drive the growth of this market in Asia
Pacific region.
The Middle East and Africa holds the least share in the
market owing to the presence of poor and slow developing countries, especially,
in African region.
MAJOR
TABLE OF CONTENTS:
1 Report Prologue
2 Market Introduction
3 Research Methodology4 Market Dynamics
5 Market Factor Analysis
6 Global Pharmaceutical Contract Manufacturing
Market By Types7 Global Pharmaceutical Contract Manufacturing Market By Regions
8 Company Landscape
9 Company Profile
10
Appendix
11 List of Tables12 List of Figures
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment